Anti-IgE therapy and severe atopic dermatitis: A pediatric perspective

Journal of the American Academy of Dermatology

Volumn 69, Issue 5, 2013, Pages 832-834

  Lacombe Barrios, Jonathan ^a,b   Bégin, Philippe ^a,b   Paradis, Louis ^a,b   Hatami, Afshin ^b   Paradis, Jean ^a   Des Roches, Anne ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885637701     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.05.035     Document Type: Article

References (5)

1. M.V. Kopp Omalizumab: anti-IgE therapy in allergy Curr Allergy Asthma Rep 11 2011 101 106
2. J.E. Lane, J.M. Cheyney, T.N. Lane, D.E. Kent, and D.J. Cohen Treatment of recalcitrant atopic dermatitis with omalizumab J Am Acad Dermatol 54 2006 68 72
3. P.G. Vigo, K.R. Girgis, P.L. Pfuetze, M.E. Critchlow, J. Fisher, and I. Hussain Efficacy of anti-IgE therapy in patients with atopic dermatitis J Am Acad Dermatol 55 2006 168 170
4. D. Amrol Anti-Immunoglobulin E in the treatment of refractory dermatitis South Med J 103 2010 554 558
5. P.M. Heil, D. Maurer, B. Klein, T. Hultsch, and G. Stingl Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course-a randomized, placebo-controlled and double blind pilot study J Dtsch Dermatol Ges 8 2010 990 998